Your browser doesn't support javascript.
loading
Minimally invasive interval debulking surgery for advanced ovarian cancer after neoadjuvant chemotherapy.
Jorgensen, Kirsten; Melamed, Alexander; Wu, Chi-Fang; Nitecki, Roni; Pareja, Rene; Fagotti, Anna; Schorge, John O; Ramirez, Pedro T; Rauh-Hain, Jose Alejandro.
Affiliation
  • Jorgensen K; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States. Electronic address: kajorgensen@mdanderson.org.
  • Melamed A; Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA, United States.
  • Wu CF; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Nitecki R; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Pareja R; Gynecologic Oncology, Instituto Nacional de Cancerología, Bogota, Colombia.
  • Fagotti A; Department of Woman's and Child Health and Public Health Sciences, Gynecologic Oncology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Catholic University of the Sacred Heart, Rome, Italy.
  • Schorge JO; Department of Obstetrics and Gynecology, The University of Tennessee Health Science Center, Memphis, TN, United States.
  • Ramirez PT; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Rauh-Hain JA; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Gynecol Oncol ; 172: 130-137, 2023 05.
Article in En | MEDLINE | ID: mdl-36977622
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Ovarian Neoplasms / Neoadjuvant Therapy Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Gynecol Oncol Year: 2023 Type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Ovarian Neoplasms / Neoadjuvant Therapy Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Gynecol Oncol Year: 2023 Type: Article